418 related articles for article (PubMed ID: 15776232)
1. Quantitative analysis of myocardial glucose utilization in patients with left ventricular dysfunction by means of 18F-FDG dynamic positron tomography and three-compartment analysis.
Morita K; Katoh C; Yoshinaga K; Noriyasu K; Mabuchi M; Tsukamoto T; Kageyama H; Shiga T; Kuge Y; Tamaki N
Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):806-12. PubMed ID: 15776232
[TBL] [Abstract][Full Text] [Related]
2. Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction.
Vitale GD; deKemp RA; Ruddy TD; Williams K; Beanlands RS
J Nucl Med; 2001 Dec; 42(12):1730-6. PubMed ID: 11752067
[TBL] [Abstract][Full Text] [Related]
3. Blood flow-metabolism imaging with positron emission tomography in patients with diabetes mellitus for the assessment of reversible left ventricular contractile dysfunction.
Schöder H; Campisi R; Ohtake T; Hoh CK; Moon DH; Czernin J; Schelbert HR
J Am Coll Cardiol; 1999 Apr; 33(5):1328-37. PubMed ID: 10193735
[TBL] [Abstract][Full Text] [Related]
4. Decreased glycolytic metabolism in non-compaction cardiomyopathy by 18F-fluoro-2-deoxyglucose positron emission tomography: new insights into pathophysiological mechanisms and clinical implications.
Tavares de Melo MD; Giorgi MCP; Assuncao AN; Dantas RN; Araujo Filho JA; Parga Filho JR; Bierrenbach ALS; de Lima CR; Soares J; Meneguetti JC; Mady C; Hajjar LA; Kalil Filho R; Bocchi EA; Salemi VMC
Eur Heart J Cardiovasc Imaging; 2017 May; 18(8):915-921. PubMed ID: 28379356
[TBL] [Abstract][Full Text] [Related]
5. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of quantitative assessment of right ventricular glucose metabolism in patients with heart failure with reduced ejection fraction.
Tsai SY; Wu YW; Wang SY; Shiau YC; Chiu KM; Tsai HY; Lee CL; Hsu JC; Tu CM; Lin HH; Huang SH
Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2601-2609. PubMed ID: 31410543
[TBL] [Abstract][Full Text] [Related]
7. Relation between right ventricular function and increased right ventricular [18F]fluorodeoxyglucose accumulation in patients with heart failure.
Mielniczuk LM; Birnie D; Ziadi MC; deKemp RA; DaSilva JN; Burwash I; Tang AT; Davies RA; Haddad H; Guo A; Aung M; Williams K; Ukkonen H; Beanlands RS
Circ Cardiovasc Imaging; 2011 Jan; 4(1):59-66. PubMed ID: 21057116
[TBL] [Abstract][Full Text] [Related]
8. Prediction of functional recovery after revascularization in patients with coronary artery disease and left ventricular dysfunction by gated FDG-PET.
Slart RH; Bax JJ; van Veldhuisen DJ; van der Wall EE; Dierckx RA; de Boer J; Jager PL
J Nucl Cardiol; 2006; 13(2):210-9. PubMed ID: 16580957
[TBL] [Abstract][Full Text] [Related]
9. Comparison of LVEF assessed by 2D echocardiography, gated blood pool SPECT, 99mTc tetrofosmin gated SPECT, and 18F-FDG gated PET with ERNV in patients with CAD and severe LV dysfunction.
Raja S; Mittal BR; Santhosh S; Bhattacharya A; Rohit MK
Nucl Med Commun; 2014 Nov; 35(11):1156-61. PubMed ID: 25144559
[TBL] [Abstract][Full Text] [Related]
10. Relation between contractile reserve and positron emission tomographic patterns of perfusion and glucose utilization in chronic ischemic left ventricular dysfunction: implications for identification of myocardial viability.
Mélon PG; de Landsheere CM; Degueldre C; Peters JL; Kulbertus HE; Piérard LA
J Am Coll Cardiol; 1997 Dec; 30(7):1651-9. PubMed ID: 9385890
[TBL] [Abstract][Full Text] [Related]
11. Electrocardiographic-gated dual-isotope simultaneous acquisition SPECT using 18F-FDG and 99mTc-sestamibi to assess myocardial viability and function in a single study.
Matsunari I; Kanayama S; Yoneyama T; Matsudaira M; Nakajima K; Taki J; Nekolla SG; Tonami N; Hisada K
Eur J Nucl Med Mol Imaging; 2005 Feb; 32(2):195-202. PubMed ID: 15449050
[TBL] [Abstract][Full Text] [Related]
12. Validation of QGS and 4D-MSPECT for quantification of left ventricular volumes and ejection fraction from gated 18F-FDG PET: comparison with cardiac MRI.
Schaefer WM; Lipke CS; Nowak B; Kaiser HJ; Reinartz P; Buecker A; Krombach GA; Buell U; Kühl HP
J Nucl Med; 2004 Jan; 45(1):74-9. PubMed ID: 14734676
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of myocardial glucose metabolism before and after recovery of myocardial function in patients with tachycardia-induced cardiomyopathy.
Matsumoto K; Takahashi N; Ishikawa T; Sumita S; Matsushita K; Inoue N; Kobayashi T; Uchino K; Kimura K; Inoue T; Umemura S
Pacing Clin Electrophysiol; 2006 Feb; 29(2):175-80. PubMed ID: 16492304
[TBL] [Abstract][Full Text] [Related]
14. Gated cardiac 13N-NH3 PET for assessment of left ventricular volumes, mass, and ejection fraction: comparison with electrocardiography-gated 18F-FDG PET.
Khorsand A; Graf S; Eidherr H; Wadsak W; Kletter K; Sochor H; Schuster E; Porenta G
J Nucl Med; 2005 Dec; 46(12):2009-13. PubMed ID: 16330564
[TBL] [Abstract][Full Text] [Related]
15. Gated fluorine 18 fluorodeoxyglucose positron emission tomography: determination of global and regional left ventricular function and myocardial tissue characterization.
Saab G; Dekemp RA; Ukkonen H; Ruddy TD; Germano G; Beanlands RS
J Nucl Cardiol; 2003; 10(3):297-303. PubMed ID: 12794629
[TBL] [Abstract][Full Text] [Related]
16. Value and limitation of myocardial fluorodeoxyglucose single photon emission computed tomography using ultra-high energy collimators for assessing myocardial viability.
Mabuchi M; Kubo N; Morita K; Noriyasu K; Itoh Y; Katoh C; Kuge Y; Tamaki N
Nucl Med Commun; 2002 Sep; 23(9):879-85. PubMed ID: 12195093
[TBL] [Abstract][Full Text] [Related]
17. Measurement of myocardial glucose uptake in patients with ischemic cardiomyopathy: application of a new quantitative method using regional tracer kinetic information.
Wiggers H; Bøttcher M; Nielsen TT; Gjedde A; Bøtker HE
J Nucl Med; 1999 Aug; 40(8):1292-300. PubMed ID: 10450680
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of myocardial 18F-fluorodeoxyglucose positron emission computed tomography in dilated cardiomyopathy and ischemic cardiomyopathy.
Yamaguchi H; Hasegawa S; Yoshioka J; Uehara T; Hashimoto K; Kusuoka H; Kuzuya T; Hori M; Nishimura T
Ann Nucl Med; 2000 Feb; 14(1):33-8. PubMed ID: 10770578
[TBL] [Abstract][Full Text] [Related]
19. Monitoring left ventricular dilation in mice with PET.
Stegger L; Schäfers KP; Flögel U; Livieratos L; Hermann S; Jacoby C; Keul P; Conway EM; Schober O; Schrader J; Levkau B; Schäfers M
J Nucl Med; 2005 Sep; 46(9):1516-21. PubMed ID: 16157535
[TBL] [Abstract][Full Text] [Related]
20. Significant suppression of myocardial (18)F-fluorodeoxyglucose uptake using 24-h carbohydrate restriction and a low-carbohydrate, high-fat diet.
Kobayashi Y; Kumita S; Fukushima Y; Ishihara K; Suda M; Sakurai M
J Cardiol; 2013 Nov; 62(5):314-9. PubMed ID: 23810066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
